Other actives
Niacinamide
INCI: Niacinamide · vitamin B3 · nicotinamide
A practical supporting active for mild uneven tone, especially when barrier support also matters.
What it is best suited for
A practical supporting active for mild uneven tone, especially when barrier support also matters.
A supportive option for surface quality and barrier function, not the highest-impact choice for fine lines.
Can help indirectly through barrier support, but high-strength formulas may be counterproductive for reactive skin.
A supportive oil-control and barrier option, not a substitute for established acne treatments.
A practical barrier-supporting active, with higher concentrations not automatically meaning better results.
What result is realistic
A realistic improvement is possible with consistent use, but response varies by formula and context.
- Initial change
- Several weeks
- When to evaluate
- About 8–12 weeks
- Expected benefit
- Subtle
What it is and what we know
A versatile, generally well-tolerated active with practical roles in barrier support, tone, and oil-control routines.
Its usefulness depends on the goal, vehicle, concentration context, frequency, and the rest of the routine.
Who may find it irritating
Irritation potential: Low. Formula, frequency, and barrier condition change tolerability.
No special restriction is modeled here, but individual products and circumstances still matter. It is not modeled as inherently photosensitizing; sun protection still matters for most skin goals.
How a beginner can introduce it
Introduce consistently in a simple routine and adjust to tolerance.
Useful concentration depends on the ingredient form and complete formula. Ingredient order alone cannot establish a studied concentration.
What not to expect
No single ingredient guarantees a result or compensates for an irritating, inconsistent routine.
Ingredient evidence does not guarantee that every product formula performs equally.
What may duplicate it
Other actives is its functional family. Several products from this family can repeat the same role, especially when they are irritation-prone.
Same family: Bakuchiol.
Verified products containing it
No verified product yet
TIER does not recommend a formula without an official source. Compare the next-ranked ingredient while the verified catalogue grows.
View the next alternative →Evidence and uncertainty
Editorial preview. Complete source lists and clinical review are not yet published. TIER therefore avoids “best” claims and does not show a public numeric score.
Dark spots · Limited
- Evidence certainty
- Limited
- Editorial confidence
- Medium
- Published sources
- 0
- Status
- Editorial preview
- Last reviewed
- 2026-07-14
The priority score combines evidence confidence, expected benefit, tolerability, practicality, time, and relative cost. It is not an efficacy percentage.
Important uncertainty: Ingredient evidence does not guarantee that every product formula performs equally.
Fine lines · Limited
- Evidence certainty
- Limited
- Editorial confidence
- Medium
- Published sources
- 0
- Status
- Editorial preview
- Last reviewed
- 2026-07-14
The priority score combines evidence confidence, expected benefit, tolerability, practicality, time, and relative cost. It is not an efficacy percentage.
Important uncertainty: Ingredient evidence does not guarantee that every product formula performs equally.
Redness · Limited
- Evidence certainty
- Limited
- Editorial confidence
- Medium
- Published sources
- 0
- Status
- Editorial preview
- Last reviewed
- 2026-07-14
The priority score combines evidence confidence, expected benefit, tolerability, practicality, time, and relative cost. It is not an efficacy percentage.
Important uncertainty: Ingredient evidence does not guarantee that every product formula performs equally.
Acne · Limited
- Evidence certainty
- Limited
- Editorial confidence
- Medium
- Published sources
- 0
- Status
- Editorial preview
- Last reviewed
- 2026-07-14
The priority score combines evidence confidence, expected benefit, tolerability, practicality, time, and relative cost. It is not an efficacy percentage.
Important uncertainty: Ingredient evidence does not guarantee that every product formula performs equally.
Skin barrier · Moderate
- Evidence certainty
- Moderate
- Editorial confidence
- Medium
- Published sources
- 0
- Status
- Editorial preview
- Last reviewed
- 2026-07-14
The priority score combines evidence confidence, expected benefit, tolerability, practicality, time, and relative cost. It is not an efficacy percentage.
Important uncertainty: Ingredient evidence does not guarantee that every product formula performs equally.
Next best alternative
Azelaic acid is the next-ranked option for Dark spots. Compare it before adding another active.
Compare alternatives